Ma C. Cantero-Ruiz

Barcelona, CT 08028, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Pain Outcome Determines the Sensitivity to Peripheral Opioid Antagonism of Morphine, Ibuprofen, and Their Combination in Laparotomized Mice.

Pain Outcome Determines the Sensitivity to Peripheral Opioid Antagonism of Morphine, Ibuprofen, and Their Combination in Laparotomized Mice.

Journal: Pharmaceutics

Published: January 26, 2026

Prescription Trends and Clinical Decision-Making in Neuropathic Pain Pharmacological Treatment: Results From a Cross-Sectional Survey by the Spanish Pain Society.

Prescription Trends and Clinical Decision-Making in Neuropathic Pain Pharmacological Treatment: Results From a Cross-Sectional Survey by the Spanish Pain Society.

Journal: European journal of pain (London, England)

Published: November 15, 2025

Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ1R Agonists/HDAC Inhibitor Dual-Acting Compounds.

Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ1R Agonists/HDAC Inhibitor Dual-Acting Compounds.

Journal: ChemMedChem

Published: October 16, 2025

Generation and phenotypic characterization of a sigma-1 receptor knockout rat.

Generation and phenotypic characterization of a sigma-1 receptor knockout rat.

Journal: Life sciences

Published: June 11, 2025

Sigma-1 receptor antagonism as a promising strategy for postoperative pain treatment: A study in laparotomized mice.

Sigma-1 receptor antagonism as a promising strategy for postoperative pain treatment: A study in laparotomized mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 24, 2025

Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties.

Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties.

Journal: Journal of medicinal chemistry

Published: January 17, 2025

Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds.

Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds.

Journal: European journal of medicinal chemistry

Published: September 13, 2024

Pharmacological differences in postoperative cutaneous sensitivity, pain at rest, and movement-induced pain in laparotomized mice.

Pharmacological differences in postoperative cutaneous sensitivity, pain at rest, and movement-induced pain in laparotomized mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 03, 2024

The role of neutrophils in pain: systematic review and meta-analysis of animal studies.

The role of neutrophils in pain: systematic review and meta-analysis of animal studies.

Journal: Pain

Published: March 26, 2024

Sigma-1 Receptors Control Neuropathic Pain and Peripheral Neuroinflammation After Nerve Injury in Female Mice: A Transcriptomic Study.

Sigma-1 Receptors Control Neuropathic Pain and Peripheral Neuroinflammation After Nerve Injury in Female Mice: A Transcriptomic Study.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: December 20, 2023

Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity.

Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity.

Journal: Journal of medicinal chemistry

Published: August 03, 2023

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.

Journal: Journal of medicinal chemistry

Published: July 07, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026